EFFECT OF ETHANOL ON LOW-DENSITY-LIPOPROTEIN AND PLATELET COMPOSITION

被引:6
|
作者
HOJNACKI, JL
CLUETTEBROWN, JE
DESCHENES, RN
MULLIGAN, JJ
OSMOLSKI, TV
RENCRICCA, NJ
BARBORIAK, JJ
JAKUBOWSKI, JA
机构
[1] ZABLOCKI VET ADM MED CTR, MILWAUKEE, WI 53295 USA
[2] ELI LILLY & CO, INDIANAPOLIS, IN 46285 USA
关键词
D O I
10.1007/BF02535972
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was designed to investigate the effect of ethanol (EtOH) dose on low density lipoprotein (LDL) and platelet composition. Male squirrel monkeys were divided into three groups designated Control, Low, and High EtOH, and fed isocaloric liquid diets containing 0%, 12%, and 24% of calories as EtOH, respectively. After four months of treatment, monkeys fed the 12% alcohol dose had LDL and platelet cholesterol concentrations similar to Controls. By contrast, platelet membranes from High EtOH animals contained significantly more cholesterol which was associated with higher levels of plasma LDL cholesterol and apolipoprotein B. Blood platelet count, size, and mass were similar for all groups and circulating platelet aggregates were absent in the two alcohol cohorts. Despite elevations in platelet cholesterol mass and thromboxane A2 (TXA2) precursor, phospholipid arachidonate, platelet responsiveness, measured as thromboxane formed in response to a collagen challenge in vitro, and the cholesterol/phospholipid molar ratio, were not significantly altered by high dose alcohol. Normal platelet activity in High EtOH monkeys may have resulted from a significant increase in the platelet phospholipid polyunsaturated/saturated fatty acid ratio and a non-significant increase in platelet phospholipid mass, both of which would have a fluidizing effect on platelet membranes. Our data indicate that low EtOH intake has no effect on platelet composition and function while unfavorable platelet cholesterol enrichment following consumption of high dose ethanol may arise from elevations in plasma LDL. Potentially thrombogenic (TXA2 formation, platelet aggregate formation) consequences of increased platelet cholesterol in squirrel monkeys fed high levels of alcohol may be averted by compensatory physicochemical changes in platelet membrane lipid composition although persistent elevations in circulating LDL may contribute to increased risk of cardiovascular disease.
引用
收藏
页码:884 / 890
页数:7
相关论文
共 50 条
  • [31] INVIVO IMAGING OF LOW-DENSITY-LIPOPROTEIN
    TWEDDEL, A
    MARTIN, W
    DAGEN, M
    LIEBERMAN, P
    SHEPHERD, J
    HUTTON, I
    BRITISH HEART JOURNAL, 1990, 64 (01): : 99 - 99
  • [32] INDICATIONS FOR LOW-DENSITY-LIPOPROTEIN APHERESIS
    GORDON, BR
    STEIN, E
    JONES, P
    ILLINGWORTH, DR
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (11): : 1109 - 1112
  • [33] THE EFFECT OF HYPOLIPEMIC DRUGS ON SUBFRACTIONS OF PLASMA LOW-DENSITY-LIPOPROTEIN
    GRIFFIN, B
    CASLAKE, M
    GAW, A
    SINNOTT, M
    YIP, B
    PACKARD, C
    SHEPHERD, J
    ATHEROSCLEROSIS, 1990, 85 (01) : 93 - 93
  • [34] THE ANTIOXIDANT EFFECT OF SPERMINE NONOATE IN HUMAN LOW-DENSITY-LIPOPROTEIN
    GOSS, SPA
    HOGG, N
    KALYANARAMAN, B
    CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (05) : 800 - 806
  • [35] THE EFFECT OF PRAVASTATIN IN RELATION TO LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY
    HAYASHI, H
    NAITO, C
    ITO, H
    KAWAMURA, M
    MIYAZAKI, S
    CURRENT MEDICAL RESEARCH AND OPINION, 1990, 12 (02) : 100 - 107
  • [36] LOW-DENSITY-LIPOPROTEIN KINETICS IN A FAMILY HAVING DEFECTIVE LOW-DENSITY-LIPOPROTEIN RECEPTORS IN WHICH HYPERCHOLESTEROLEMIA IS SUPPRESSED
    VEGA, GL
    HOBBS, HH
    GRUNDY, SM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03): : 578 - 585
  • [38] INVOLVEMENT OF THE MACROPHAGE LOW-DENSITY-LIPOPROTEIN RECEPTOR-BINDING DOMAINS IN THE UPTAKE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN
    KEIDAR, S
    BROOK, GJ
    ROSENBLAT, M
    FUHRMAN, B
    DANKNER, G
    AVIRAM, M
    ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (04): : 484 - 493
  • [39] THE EFFECT OF LOVASTATIN TREATMENT ON LOW-DENSITY-LIPOPROTEIN HYDRATED DENSITY DISTRIBUTION AND COMPOSITION IN PATIENTS WITH INTERMITTENT CLAUDICATION AND PRIMARY HYPERCHOLESTEROLEMIA
    TILLYKIESI, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (06): : 623 - 628
  • [40] ATHEROGENIC LEVELS OF LOW-DENSITY-LIPOPROTEIN ALTER THE PERMEABILITY AND COMPOSITION OF THE ENDOTHELIAL BARRIER
    GURETZKI, HJ
    GERBITZ, KD
    OLGEMOLLER, B
    SCHLEICHER, E
    ATHEROSCLEROSIS, 1994, 107 (01) : 15 - 24